Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Recruiting

Phase 1

Evaluation of Kamuvudine-8 in Subjects With Geographic AtrophyEvaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Sponsor:

University of Kentucky

Code:

NCT06164587

Conditions

Geographic Atrophy

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by University of Kentucky on 2025-03-25.